Massachusetts General Hospital Heart Center

Boston, Massachusetts 02114

0 studies enrolling now · 3 studies all time

What they study most

Congenital Heart Disease, Congenital Heart Disease With Fontan Circulation, Severe Hypertriglyceridemia

Studies at this site

• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects — Completed
• An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients. — Stopped early